HomeTagsSGX

SGX

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Why Beng Kuang Marine Could Surprise Investors In 2026

Why the "Boring" Side of Energy is Winning The offshore oil and gas sector has...
SGX-LISTED COMPANIES

Why Singapore’s Data Center Constraints Are Its Greatest Asset

Introduction: The Invisible Gated Community of the Internet The digital "cloud" is frequently marketed as...
SGX-LISTED COMPANIES

How Helens International Turned A Massive Loss Into A Huge Win In FY2025

The Strategy of Subtraction: How Helen’s Found Profit in a 28% Revenue Retreat In the...
SGX-LISTED COMPANIES

Zero Debt, High Dividends & Strategic Real Estate – Inside Reclaims Global’s FY2026 Transformation

Introduction In the high-octane world of Singapore’s construction services, the traditional playbook is one of...
SGX-LISTED COMPANIES

Will Singtel’s Rally Continue Or Slowdown In 2026?

A Year of Unprecedented Gains As of March 2026, Singapore Telecommunications Ltd (Singtel) has managed...
SGX-LISTED COMPANIES

The Assembly Place FY2025 – Singapore’s Fastest Growing Community Living Giant

4 Surprising Takeaways from Singapore’s Fastest-Growing Community Living Giant The landscape of urban residency is...
SGX-LISTED COMPANIES

Accounting Alchemy & The Radical Slim-Down At Tan Chong International FY2025

The 920% Surprise To the uninitiated, the 2025 annual results of Tan Chong International Limited...
SGX-LISTED COMPANIES

Thakral Corporation FY2025 Sees A S$174 Million Surge

Why Losing Influence in GemLife Was Thakral’s Strategic Masterstroke Sophisticated retail investors often find themselves...
SGX-LISTED COMPANIES

Tianjin Pharmaceutical Da Ren Tang Is Shrinking To Succeed In FY2025

How TJ DRT’s 33% Revenue "Loss" Fueled a 72% Margin Miracle and a Record...
SGX-LISTED COMPANIES

Sales Are Up, But Where’s The Cash? China Kangda Food FY2025

4 Surprising Takeaways from China Kangda’s 2025 Financials China Kangda Food Company Limited occupies a...
SGX-LISTED COMPANIES

The Strategy Keeping Camsing Healthcare Alive – FY2026

The Survival Pivot: 4 Lessons from a Retail Healthcare Turnaround Introduction: The narrative of the legacy...
SGX-LISTED COMPANIES

How Geopolitics & Administrative Faults Left Ouhua Energy Fighting For Air In FY2025

https://open.spotify.com/episode/2MRrUHNo4mAmqYqJhej1pr?si=3e230667e6cf4daf Introduction: The High-Stakes World of Energy The global energy sector is a theater of the...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...